Nano Pharmaceuticals
Market Cap
₹155 ₹155 Cr.
P/E
51.69
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Market cap
Market cap
155 Cr
PE
PE
51.69
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
0.97
ROCE (%)
ROCE (%)
1.24
Div Yield (%)
Div Yield (%)
-
Sales
Sales
46.35 Cr
OPM (%)
OPM (%)
8.41 %
Debt to Equity
Debt to Equity
-
Institutions
Institutions
-
Individual < 2 lac
Individual < 2 lac
23.25 %
No. of Shareholders
No. of Shareholders
8,038

About

Tarajyot Polymers Ltd is a subsidiary of Government of Kerala undertaking and Gujarat Inject (… Read more
Low
2
52W Range
High
14
  • Guj. Inject (Kerala)
  • Parnax Lab
  • Auro Laboratories

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

3 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Gujarat Inject (Kerala) Ltd. Business

Tarajyot Polymers Ltd, a subsidiary of the Government of Kerala, specializes in the production and distribution of pharmaceutical products and medical equipment. They offer a wide range of items including bulk drugs, formulation chemicals, intravenous fluids, and disposable medical instruments.

Guj. Inject (Kerala) major competitors are Parnax Lab, Auro Laboratories, Balaxi Pharma., Syschem (India), Panchsheel Organics, HR Hygiene Products, Aayush Wellness.
Market Cap of Guj. Inject (Kerala) is ₹155 Crs.
While the median market cap of its peers are ₹147 Crs.

Guj. Inject (Kerala) seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release May Jul
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material